2017•Journal of Thoracic OncologyOpen access

P3.01-037 Understanding Mechanisms of Resistance to Osimertinib by Circulating Tumor DNA Genotyping in Advanced Non-Small-Cell Lung Cancer

Yingying Du, Wanchun Zang, G. Wang, Yun Sang, Fei Gai, L. Li, Yueqian Yu, Gang Cheng, Pan Yu, Gengyun Sun

Open full text 1 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

Open-access reader

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Osimertinib, T790M, Medicine, Lung cancer, Gefitinib, Erlotinib, Genotyping, Oncology

Back to paper search Browse research topics Original source

P3.01-037 Understanding Mechanisms of Resistance to Osimertinib by Circulating Tumor DNA Genotyping in Advanced Non-Small-Cell Lung Cancer — Research Paper | ScholarLens